Researchers can invent and test millions of molecules quickly, but to develop successful new drugs, agrochemicals and other futuristic materials, they must first synthesize the molecules—and outcomes are a gamble. To solve this problem, Timothy Cernak’s laboratory at the University of Michigan College of Pharmacy was awarded $3 million by Schmidt Futures recently to develop molecular reaction data using high-throughput experimentation, and the software to process it. The data will be available to all and the software will be free to academia. Read the full article here.
Recent Posts
- Join us on Wednesday, October 1st, 2025 for the 5th Annual Drug Discovery Symposium!
- Courage Therapeutics receives $7.8M investment to advance weight regulation drugs
- Integrated stress response plasticity governs normal cell adaptation to chronic stress via the PP2A-TFE3-ATF4 pathway
- A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance
- Tim Cernak sat down with Michigan Public radio show Stateside to discuss what role pharmacists can play in decreasing plant and animal extinctions.
